Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Levodopa in restless legs.

C von Scheele

    Lancet (London, England)
    |August 23, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Levodopa effectively treats restless legs syndrome, with 17 of 20 patients preferring it over lactose. Those who responded to levodopa experienced complete symptom relief.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Grading scale of radiographic findings in the pubic bone and symphysis in athletes.

    Acta radiologica (Stockholm, Sweden : 1987)·2003
    Same author

    Levodopa dependence and abuse in Parkinson's disease.

    Pharmacotherapy·1997
    Same author

    Influence of anode-filter combinations on image quality and radiation dose in 965 women undergoing mammography.

    Radiology·1997
    Same author

    Long-term effect of dopaminergic drugs in restless legs. A 2-year follow-up.

    Archives of neurology·1990
    Same author

    A study of so-called hypochondriasis.

    Psychotherapy and psychosomatics·1990
    Same author

    [Meige's or Brueghel's syndrome? A neurologic disease that is possible to treat].

    Lakartidningen·1989
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    See all related articles

    Area of Science:

    • Neurology
    • Pharmacology

    Background:

    • Restless Legs Syndrome (RLS) is a neurological disorder characterized by an irresistible urge to move the legs.
    • Current treatments for RLS have varying efficacy and side effect profiles.

    Purpose of the Study:

    • To evaluate the efficacy of levodopa in managing Restless Legs Syndrome symptoms.
    • To compare patient preference between levodopa and lactose in a double-blind setting.

    Main Methods:

    • A double-blind, placebo-controlled trial involving 20 patients diagnosed with RLS.
    • Patients received levodopa and lactose on alternate days.
    • Treatment duration was determined by patient preference or inability to differentiate between treatments.

    Main Results:

    Related Experiment Videos

  • 17 out of 20 patients (85%) expressed a preference for levodopa.
  • No patients preferred lactose.
  • 3 patients were unable to distinguish between levodopa and lactose.
  • Patients who preferred levodopa reported complete relief from RLS symptoms.

    • Conclusions:

    • Levodopa demonstrates significant effectiveness in treating Restless Legs Syndrome.
    • Patient preference strongly favors levodopa for RLS symptom management.
    • Levodopa offers a promising therapeutic option for individuals suffering from Restless Legs Syndrome.